PDL BioPharma, Inc. Deferred Tax Assets, Net of Valuation Allowance, Current
PDL BioPharma, Inc. had Deferred Tax Assets, Net of Valuation Allowance, Current of $235.00 thousand as of 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2013-05-09
- 2013-03-31: Deferred Tax Assets, Net of Valuation Allowance, Current $235.00K.
- 2012-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $1.61M.
- 2012-09-30: Deferred Tax Assets, Net of Valuation Allowance, Current $3.55M.
- 2012-06-30: Deferred Tax Assets, Net of Valuation Allowance, Current $5.16M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2013-03-31 | $235.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $1.61M 10-Q · filed 2013-05-09 |
| 2012-09-30 | $3.55M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $5.16M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $10.75M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $10.05M 10-K · filed 2013-03-01 |
| 2011-09-30 | $13.54M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $10.44M 10-Q · filed 2011-07-29 |
| 2011-03-31 | $17.06M 10-Q · filed 2011-04-28 |
| 2010-12-31 | $19.90M 10-K · filed 2012-02-23 |
| 2009-12-31 | $1.27M 10-K · filed 2011-03-01 |